Jump to search

September 2021

NIH grant funds new study to evaluate heart failure in California Central Valley patients

September 21, 2021

Martin Cadeiras, Javier E. López and Nipavan Chiamvimonvat are co-principal investigators for a $1.5 million grant from the National Institute of Health to take a precision medicine approach to evaluate patients with a poorly understood form of heart failure.

Veronica Ahumada brings human-robot interaction expertise to UC Davis Health

September 16, 2021

Veronica Ahumada joined UC Davis Health this year and brought her expertise in health informatics and human-robot interaction to the UC Davis Center for Health and Technology. She will be growing her research through two exciting grant-funded projects involving robots.

August 2021

Busting myths about diabetic ketoacidosis, a common but serious complication of diabetes

August 26, 2021

In a Q&A, Pediatrician Nicole Glaser discusses the causes, symptoms and treatment of DKA in children with Type I diabetes.

UC Davis and the School of Medicine set new records in research funding

August 25, 2021

UC Davis set a new record for external research funding, receiving $968 million in awards in the fiscal year 2020-21. The School of Medicine received the largest increase in funding, up 33% from the previous year.

Video game makes speech therapy fun for children with cleft palates

August 20, 2021

For more than seven years, UC Davis Health experts Travis Tollefson and Christina Roth have partnered with UC Santa Cruz researchers to provide feedback and testing of SpokeIt, a UC Santa Cruz-developed game. SpokeIt provides a tool that incentivizes children to improve their speech. 

UC Davis School of Medicine partners with Pfizer to study COVID-19 booster vaccine

August 13, 2021

UC Davis Health has chosen 60 people to participate in a clinical trial to determine if a Pfizer COVID-19 booster shot is necessary, safe and effective. The participants are among 225 who signed up more than a year ago for the clinical trial that led to the FDA Emergency Use Authorization of the Pfizer vaccine.

Study explains why food high in saturated fat may lead to plaque build-up in arteries

August 13, 2021

A new study suggests that eating food rich in saturated fat and choline increases metabolites that build plaques in the arteries. It also points to a possible drug that may block the negative effects of the high-fat diet.

Study suggests holistic admissions policies increase medical school diversity

August 6, 2021

New study by School of Medicine faculty members confirms the importance of pre-med Postbaccalaureate programs to better prepare medical school applicants. The programs are also known to increase diversity of applicants from underrepresented and disadvantaged backgrounds.

Is reducing opioids for pain patients linked to higher rates of overdose and mental health crisis?

August 3, 2021

A UC Davis Health study published in JAMA found a 68% increase in overdose events and a doubling of mental health crises among patients who were on stable opioid therapy but saw their doses tapered.

Two-thirds of California firearm owners with children do not store guns in recommended way

August 3, 2021

Firearm injuries are among the leading causes of death for children and adolescents in the U.S., but a new study finds two-thirds of firearm-owning adults in California who live with children do not store their guns safely, locked up and unloaded.

June 2021

Study confirms the low likelihood that SARS-CoV-2 on hospital surfaces is infectious

June 24, 2021

A new study confirms the low likelihood that coronavirus contamination on hospital surfaces is infectious. The study is the original report on recovering near-complete SARS-CoV-2 genome sequences directly from surface swabs.

Research provides a roadmap to HIV eradication via stem cell therapy

June 23, 2021

A groundbreaking study found that stem cells reduce the amount of virus causing AIDS, boost the body’s antiviral immunity, and restore the gut’s lymphoid follicles damaged by HIV. It provided a roadmap for multi-pronged HIV eradication strategies.

Switching from Western diet to a balanced diet may reduce skin, joint inflammation

June 22, 2021

Diet rich in sugar and fat leads to disruption in the gut’s microbial culture and contributes to inflammatory skin diseases such as psoriasis. Research shows that switching to a more balanced diet restores the gut’s health and suppresses inflammation.

New grants awarded for projects to improve mental health for Californians

June 21, 2021

UC Davis' Behavioral Health Center of Excellence has awarded three seed grants to help support new research efforts aimed at improving mental health in California.

UC Davis Health scientist awarded Pew Scholarship to beat bacteria behind tuberculosis

June 18, 2021

Bennett Penn, assistant professor of infectious diseases and of medical microbiology and immunology, has been named a 2021 Pew Scholar in the Biomedical Sciences. He will receive funding over the next four years to investigate how bacteria causing tuberculosis build resistance to antibiotics.

UC Davis Clinical and Translational Science Center awarded 5-year grant renewal from NIH

June 17, 2021

The Clinical and Translational Science Center (CTSC) received notice of its third NIH award renewal. The 5-year award, almost $33 million, provides critical funding to continue CTSC’s essential services for the UC Davis research community.

MIND Institute brain bank focused on autism, diversity, education and research

June 7, 2021

The new CENE Brain Bank, supported by the MIND Institute, aims to increase the diversity of brain tissue available for research about autism and other neurodevelopmental conditions. The project includes collection sites in Latin American countries.

Rapid whole genome sequencing leads to better outcomes for babies, lower medical costs

June 4, 2021

A study published today outlined the success of Project Baby Bear, a real-world quality improvement program designed to test the clinical and economic value of using rapid Whole Genome Sequencing to diagnose and guide treatment for infants with unexplained rare disease.

Most Californians unaware of law to prevent gun violence but would support using it

June 4, 2021

A new study shows that two-thirds of Californians don’t know about a law designed to prevent a person at risk of hurting themselves or others from possessing or purchasing firearms or ammunition. More than 80% of survey participants were supportive once they read about this law.

Researchers discover potential new approach to treating psoriatic joint inflammation

June 3, 2021

An international team of researchers, led by UC Davis Health, developed a new therapeutic approach to treating psoriatic arthritis, a chronic inflammatory disease affecting the joints.

May 2021

More work still needed to recruit, retain OB/GYN residents that reflect the diverse patient population they serve

May 26, 2021

To address health care disparities among minority women in obstetrics and gynecology, one approach is to increase diversity among health care providers to better reflect the patient population that they serve. But are medical residents within OB/GYN more diverse than other medical specialties?

A call to gynecologic surgeons to reduce excess opioid pills after hysterectomy

May 19, 2021

A UC Davis Health study urged gynecologic surgeons to prescribe the smallest effective opioid prescription after hysterectomy. Their study found that, on average, patients use only half of pills prescribed after the operation.

UC Davis MIND Institute to host inaugural stem cell, gene therapy conference

May 11, 2021

The UC Davis MIND Institute is now accepting abstracts for its first-ever Stem Cell and Gene Therapy for Neurodevelopmental Disorders Conference. The September event will feature both in-person and virtual options and will focus on the development of treatments for genetic disorders.

UC Davis Health now enrolling children ages 12-17 for Novavax coronavirus vaccine trial

May 7, 2021

UC Davis Health will soon launch a stage 3 clinical trial for a new coronavirus vaccine for children ages 12-17 with the National Institutes of Health (NIH) and Novavax. The two-year study aims to enroll 100 participants.

April 2021

Calibrating Lactoferrin protein in milk may boost learning and protect neurons

April 29, 2021

Lactoferrin is a glycoprotein found naturally in breast milk. A study by UC Davis Professor Fredric A. Troy II found that the lactoferrin concentration in the diet has significantly different impacts on learning, brain development and neuroprotection.

PsychLight sensor to enable discovery of new psychiatric drugs

April 28, 2021

UC Davis researchers develop PsychLight, a sensor that could be used in discovering new treatments for mental illness, in neuroscience research and to detect drugs of abuse.

Promising gene therapy for Duchenne muscular dystrophy

April 28, 2021

Clinical researchers at UC Davis Health are using an innovative gene therapy approach for Duchenne muscular dystrophy, which the lead physician hopes will be a transformational treatment for children with the disease.

Celebrating translational science researchers at UC Davis

April 23, 2021

During its 16th annual CTSC Scholar Symposium, UC Davis celebrated the graduation of its newest cohort of scholars who conduct innovative applied health research.

MIND Institute study of anxiety in children with autism now includes online treatment

April 20, 2021

The UC Davis MIND Institute is now offering online treatment as part of its clinical trial known as the STAAR study. The trial will compare the effectiveness of the medication sertraline and cognitive behavioral therapy in treating anxiety in children with autism.

New test to study language development in youth with Down syndrome

April 8, 2021

A team led by UC Davis Health researchers tested and validated a new set of procedures for collecting, measuring and analyzing the spoken language of youth with Down syndrome in a naturalistic setting.

March 2021

Nexplanon birth control study seeks participants

March 9, 2021

UC Davis Health is now enrolling women in a new study to extend Nexplanon’s use to five years. Nexplanon is a contraceptive implant that is inserted under the skin of the upper arm to provide birth control. The implant is currently approved for three years of use.  

New research seeks to reduce birth injury causing shoulder, arm and hand paralysis

March 9, 2021

New study evaluates maternal and hospital factors possibly linked to risk of brachial plexus birth injury, the leading cause of infants’ upper extremity paralysis.

Enhancing California’s specialty crops

March 4, 2021

UC Davis’ Center for Precision Medicine and Data Sciences will be helping to enhance the competitiveness of California’s specialty crops thanks to a new grant.

First stem cell clinical trial for spina bifida treatment announced

March 1, 2021

A UC Davis Health team today announced the launch of the world’s first FDA-approved human clinical trial to treat the most serious form of spina bifida. The trial involves the use of stem cells, applied during a surgery before birth.

February 2021

New mini-medical school seeks to engage, serve Sacramento’s Vietnamese community

February 26, 2021

Vietnamese mini-medical school, an educational outreach effort by CTSC program and the Alzheimer’s Disease Research Center, is open for registration.

UC Davis School of Medicine scored a record year of NIH funding

February 23, 2021

In 2020, the UC Davis School of Medicine secured its highest-ever level of National Institutes of Health research funding at more than $181 million.

UC Davis Health joins Mount Sinai, Cleveland Clinic and Northwestern in grant to implement and evaluate IBD Digital Therapeutics Toolkit within EHR

February 19, 2021

UC Davis Health has joined with several of the nation’s top health systems to help launch a NIH-sponsored initiative for an new digital therapeutics toolkit targeting inflammatory bowel disease.

January 2021

Twelve COVID-19 treatments being tested at UC Davis School of Medicine

January 28, 2021

In the search for potential COVID-19 treatments, UC Davis School of Medicine is recruiting participants for more than 12 clinical trials.

UC Davis receives $3.2 million grant to study age-related macular degeneration

January 19, 2021

Glenn Yiu, an associate professor in the Department of Ophthalmology and Vision Science, has been awarded a five-year, $3.2 million grant from the National Institutes of Health National Eye Institute for a study on age-related macular degeneration, or AMD.

Fewer behavior problems in young foster care kids after PC-CARE program

January 14, 2021

A new study finds that young children in the foster care system demonstrated fewer behavior problems after participating in an innovative seven-week intervention. The program is called PC-CARE, and was pioneered at UC Davis CAARE Center.

Exposure to violence takes a toll on the socioemotional well-being of Californians

January 14, 2021

A survey of Californians finds that exposure to violence has pervasive social and emotional impacts on people, especially when firearms are involved.

Research on COVID-19 vaccine includes data from UC Davis School of Medicine

January 13, 2021

The New England Journal of Medicine published a peer-reviewed paper on the newly available Pfizer COVID-19 vaccine. It includes clinical trial data collected from UC Davis Health, the only academic medical center on the West Coast to take part in the study.

Innovative serotonin sensor to improve neurological drug development

January 11, 2021

UC Davis researchers developed and used an innovative sensor to track serotonin in the brains of mice during social interactions, fearful situations and sleep/wake conditions. Sensor can help in developing better neuropsychological drugs for depression and other conditions.

Concerns about violence increase in California amid COVID-19 pandemic

January 4, 2021

Study finds that people in California are more worried about violence during COVID-19 pandemic.

December 2020

UC Davis Health launches new COVID-19 vaccine trial

December 30, 2020

Participants are needed for a new clinical trial at UC Davis Health to test another experimental COVID-19 vaccine that could help address the global pandemic.

Stem cells: A possible treatment for severe respiratory failure, a COVID-19 complication

December 21, 2020

UC Davis Health scientists joined a landmark multicenter clinical trial to test the ability of a type of stem cells to treat patients with acute respiratory distress syndrome (ARDS), a life-threatening lung injury.

Big brains and white matter: New clues about autism subtypes

December 17, 2020

Researchers found that a long-accepted theory about brain size in some children with autism may not be true. In a separate study, they linked development of white matter with changes in autism symptom severity.

Wildfire smoke can carry microbes that cause infectious diseases

December 17, 2020

Wildfire smoke contains microbes, a fact that’s often ignored, but one that may have important health repercussions.

Risk factors for Valley fever among Hispanic California farmworkers

December 15, 2020

Valley fever exposure might be higher in certain agricultural tasks and types of crops, according to Prof. Stephen McCurdy’s research.

UC Davis Health is prepared to receive Pfizer COVID-19 vaccine

December 10, 2020

With an allotment of Pfizer’s COVID-19 vaccine to arrive as early as Monday, UC Davis Health is preparing its storage space and its employees for one of the most significant inoculation efforts in recent history.

Hydrogen peroxide keeps gut bacteria away from the colon lining

December 9, 2020

An enzyme in the colon lining releases hydrogen peroxide – a known disinfecting compound- to protect the body from gut microbial communities. The new study points to the need for a different approach to treating gut inflammation and bacterial imbalance in the colon.

Neurologist Michael Rogawski named fellow of the National Academy of Inventors

December 8, 2020

Michael Rogawski has been elected a fellow of the National Academy of Inventors, the highest professional distinction given to academic inventors, for his inventions in drug discovery and development.

UC Davis Health joins Novavax in testing a new COVID-19 vaccine

December 7, 2020

UC Davis Health launches a COVID-19 clinical trial with Novavax to test a new coronavirus vaccine. This vaccine has an important advantage: liquid state storage that allows for distribution using standard vaccine channels, unlike the Pfizer and Moderna vaccines that must be stored at subzero temperature.

Kidney and brain injuries linked to diabetic ketoacidosis

December 4, 2020

UC Davis Health experts have identified factors that make children with diabetic ketoacidosis more likely to experience acute kidney injury. The results may eventually lead to new options and better treatments for the dangerous condition. 

November 2020

Obesity affects stem cell transplants for cancer, blood disorder treatments

November 25, 2020

Led by a UC Davis Health team, researchers have found that obesity can block the benefits of a stem cell transplant when it is used for treating blood cancers and other related disorders.

School of Medicine team contributes to special issue of Birth Defects Research

November 18, 2020

A UC Davis research team, consisting of postdoctoral fellows, graduate students and undergraduates led by Chengji Zhou, professor of biochemistry and molecular medicine at the UC Davis School of Medicine, has made major contributions to the latest issue of Birth Defects Research. This issue was published online this month.

Breathing problems in teens: COVID-19 or lung injury due to vaping?

November 17, 2020

Lung injury due to e-cigarette use (EVALI) and COVID-19 share many symptoms. Providers need to get the vaping history of teenagers with unexplained breathing problems.

State stem cell agency funds clinical trial for spina bifida treatment

November 12, 2020

California’s stem cell agency awarded funding to UC Davis Health researchers for the first human clinical trial using stem cells to treat spina bifida.

Young survivors of acute myeloid leukemia have long-term complications from treatment

November 9, 2020

Adolescent and young adult patients treated for acute myeloid leukemia have a high risk of developing several long-term health complications after treatment.

Does breastfeeding lower mother’s breast cancer risk?

November 5, 2020

Less than 40% of women in the U.S. know that breastfeeding lowers breast cancer risk.

Jennifer Doudna on CRISPR, coronavirus and curiosity-driven research

November 3, 2020

2020 Nobel Laureate Jennifer Doudna gave a fascinating talk on CRISPR and its potential to improve diagnosis and treatment of COVID-19.

October 2020

The CTSC paves the way for promising medical researchers through KL2 awards

October 27, 2020

CTSC encourages medical researchers to apply now to KL2 Mentored Career Development grants.

Cord blood DNA can hold clues for early ASD diagnosis and intervention

October 22, 2020

Specific regions in cord blood DNA can help identify kids who might develop autism.

For toddlers with autism, more intervention hours are not necessarily better

October 19, 2020

Two prominent early intervention models for toddlers with autism show a very similar impact, whether delivered at 15-hours or 25-hours per week intensities.

2020 Nobel Laureate Jennifer Doudna guest speaker on CRISPR and coronavirus (Oct. 30)

October 16, 2020

2020 Nobel Laureate Jennifer Doudna guest speaker at the upcoming Distinguished Speaker Series in Research and Innovation.

NICU webcam program positively impacts parents, study finds

October 14, 2020

NICU parents feel more involved in their infant’s care, more likely to provide breastmilk to their baby when they can watch their child in the NICU, thanks to a webcam.

Can an antibody ‘cocktail’ prevent COVID-19 infection?

October 12, 2020

In a new COVID-19 clinical trial, Stuart Cohen at UC Davis Health tests monoclonal antibody combination to prevent COVID-19 in adults exposed to infected patients.

UC Davis School of Medicine and UTHealth get nearly $54 million to study the role of white matter lesions in dementia

October 5, 2020

Brain scientists from UC Davis School of Medicine and The University of Texas Health Science Center have been awarded a six-year, $53.6 million grant from the National Institutes of Health to determine the role of incidental white matter lesions, or WMLs, in dementia.

UC Davis to offer free COVID-19 testing for Central Valley farmworkers

October 1, 2020

Four UC Davis research centers will partner with 10 community organizations to offer free COVID-19 testing for Central Valley farmworkers under a new federal grant